Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

13.65USD
4:00pm EDT
Price Change (% chg)

$0.56 (+4.28%)
Prev Close
$13.09
Open
$13.14
Day's High
$13.79
Day's Low
$12.92
Volume
515,774
Avg. Vol
645,189
52-wk High
$38.82
52-wk Low
$10.77

CLDX.OQ

Chart for CLDX.OQ

About

Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's drug candidates include CDX-110, CDX-011 and CDX-1127. CDX-110, is an immunotherapeutic... (more)

Overall

Beta: 2.51
Market Cap (Mil.): $1,169.69
Shares Outstanding (Mil.): 89.36
Dividend: --
Yield (%): --

Financials

  CLDX.OQ Industry Sector
P/E (TTM): -- 103.84 36.07
EPS (TTM): -1.12 -- --
ROI: -37.26 -0.24 18.18
ROE: -38.67 -1.24 19.05
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks